Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs W W Grainger Inc (GWW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs W W Grainger Inc — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.66 (market cap $3.94B), while W W Grainger Inc trades at $1,330.68 (market cap $62.41B). The key difference: W W Grainger Inc is far larger — about 15.8× Edgewise Therapeutics Inc. Common Stock's market cap, and W W Grainger Inc pays a 0.75% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and W W Grainger Inc for 26 Days on average.
| EWTX | GWW | |
|---|---|---|
Market Cap | $3.94B | $62.41B |
Volume | 810,104 | 284,715 |
Sector | Health | Industrials |
52-Week High | $48.35 | $1.40K |
52-Week Low | $14.89 | $918.18 |
Typical Hold Time | 0 Days | 26 Days |
Enterprise Value | $3.48B | $64.62B |
Dividend Yield | — | 0.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GWW trades at $1,325.10, up 1.41% today, with a bullish technical signal and strong fundamentals including a 47.92% ROE and 9.92% net income margin. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a solid dividend as a Dividend King. Institutional buying and positive analyst coverage support the stock's momentum.
Outlook remains positive with a consensus price target of $1,310, though high valuation multiples and competitive pressures pose risks. Earnings growth and market share gains in industrial distribution are key drivers for continued upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About W W Grainger Inc
Grainger is a leading broad-line distributor of maintenance, repair, and operating (MRO) products. It serves millions of customers worldwide through an integrated network of branches and digital platforms.
Read more on GWW →
